SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-22-010973
Filing Date
2022-05-13
Accepted
2022-05-13 16:31:11
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rebusholdings_10q.htm   iXBRL 10-Q 824158
2 EXHIBIT 31.1 rebusholdings_ex31-1.htm EX-31.1 11690
3 EXHIBIT 31.2 rebusholdings_ex31-2.htm EX-31.2 12186
4 EXHIBIT 32.1 rebusholdings_ex32-1.htm EX-32.1 8768
5 EXHIBIT 32.2 rebusholdings_ex32-2.htm EX-32.2 8920
  Complete submission text file 0001829126-22-010973.txt   3338823

Data Files

Seq Description Document Type Size
6 XBRL CALCULATION FILE rbsh-20220331_cal.xml EX-101.CAL 35188
7 XBRL DEFINITION FILE rbsh-20220331_def.xml EX-101.DEF 100270
8 XBRL LABEL FILE rbsh-20220331_lab.xml EX-101.LAB 202421
9 XBRL PRESENTATION FILE rbsh-20220331_pre.xml EX-101.PRE 166740
10 XBRL SCHEMA FILE rbsh-20220331.xsd EX-101.SCH 29454
47 EXTRACTED XBRL INSTANCE DOCUMENT rebusholdings_10q_htm.xml XML 390283
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Rebus Holdings, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 22923279
SIC: 2834 Pharmaceutical Preparations